Spinal Cord Injury Drug Treatment Market is Predicted to Reach New Heights with the Anticipated Launch of Emerging Therapies and Breakthroughs by 2034 | DelveInsight

Posted on by

The spinal cord injury market is expected to experience steady growth, with a strong CAGR of 15.4% forecast from 2024 to 2034. This growth across the 7MM will be propelled by the introduction of innovative therapies such as KP-100IT, Neuro-Cells, Elezanumab (ABT-555), and MT-3921. LAS…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.